Literature DB >> 9234815

Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes.

A Banemann1, R Gross.   

Abstract

Several Bordetella bronchiseptica isolates were investigated for intracellular survival in macrophages. A significant number of viable bacteria of all strains could be recovered even after 96 h postinfection. In all cases bvg mutants of the B. bronchiseptica strains showed a significant survival advantage over the respective wild-type strains. The bacteria were already located in phagolysosomes early after uptake. Neither opsonization of the bacteria nor activation of the macrophages with gamma interferon or lipopolysaccharide prior to infection affected uptake and survival of the bacteria.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234815      PMCID: PMC175492          DOI: 10.1128/iai.65.8.3469-3473.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  In vivo characterization of the unorthodox BvgS two-component sensor protein of Bordetella pertussis.

Authors:  D Beier; B Schwarz; T M Fuchs; R Gross
Journal:  J Mol Biol       Date:  1995-05-05       Impact factor: 5.469

2.  Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin.

Authors:  N Khelef; A Zychlinsky; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

3.  Mechanisms involved in uptake of Bordetella bronchiseptica by mouse dendritic cells.

Authors:  C A Guzman; M Rohde; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Epithelial cell invasion and survival of Bordetella bronchiseptica.

Authors:  H Schipper; G F Krohne; R Gross
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

5.  Gentamicin kills intracellular Listeria monocytogenes.

Authors:  D A Drevets; B P Canono; P J Leenen; P A Campbell
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Induction of cytokines in phagocytic mammalian cells infected with virulent and avirulent Listeria strains.

Authors:  M Kuhn; W Goebel
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  A phase variant of Bordetella pertussis with a mutation in a new locus involved in the regulation of pertussis toxin and adenylate cyclase toxin expression.

Authors:  N H Carbonetti; N Khelef; N Guiso; R Gross
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

8.  Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host.

Authors:  P Gueirard; C Weber; A Le Coustumier; N Guiso
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Phosphatidylinositol-specific phospholipase C from Listeria monocytogenes contributes to intracellular survival and growth of Listeria innocua.

Authors:  W R Schwan; A Demuth; M Kuhn; W Goebel
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more
  16 in total

1.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Reduced virulence of a Bordetella bronchiseptica siderophore mutant in neonatal swine.

Authors:  K B Register; T F Ducey; S L Brockmeier; D W Dyer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Phagosome acidification has opposite effects on intracellular survival of Bordetella pertussis and B. bronchiseptica.

Authors:  B Schneider; R Gross; A Haas
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure.

Authors:  Federico Sisti; Julieta Fernández; María Eugenia Rodríguez; Antonio Lagares; Nicole Guiso; Daniela Flavia Hozbor
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence.

Authors:  H Jungnitz; N P West; M J Walker; G S Chhatwal; C A Guzmán
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

9.  Bordetella bronchiseptica-mediated cytotoxicity to macrophages is dependent on bvg-regulated factors, including pertactin.

Authors:  C B Forde; X Shi; J Li; M Roberts
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

10.  Reduction of endotoxicity in Bordetella bronchiseptica by lipid A engineering: Characterization of lpxL1 and pagP mutants.

Authors:  Jesús Pérez-Ortega; Roel M Van Harten; Ria Van Boxtel; Michel Plisnier; Marc Louckx; Dominique Ingels; Henk P Haagsman; Jan Tommassen
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.